Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.2 (
alanine aminotransferase
)
26,722
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fleroxacin (FLRX), a new quinolone oral antibacterial agent, was studied in the field of obstetrics and gynecology, and the following results were obtained. 1. Clinical efficacy was evaluated in 105 patients (intrauterine infection 38, adnexitis 28, extragenital organ infection 29, others 10), with an exclusion of 9 patients out of a total of 114 patients. FLRX was orally administered at 200 mg or 300 mg once daily. 2. Clinical efficacy rates were 37/38 (97.4%) in intrauterine infection, 26/28 (92.9%) in adnexitis, 29/29 (100%) in extragenital organ infection and 10/10 (100%) in others. 3. Efficacy rates classified by isolated organisms were 23/23 (100%) in single infections by Gram-positive organisms, 11/13 (84.6%) in those by Gram-negative organisms, 8/9 (88.9%) in those by anaerobic organisms and 15/19 (78.9%) in mixed infections. 4. Side effects were observed in 4 cases (3.5%);
gastrointestinal disorder
with diarrhea and diarrhea in 1 patient each and insomnia in 2 patients. In laboratory examination, eosinophilia and elevation of GOT and
GPT
were noted in 1 patient each (1.9%). Based on the above results, we consider that FLRX is a useful drug for the obstetrical and gynecological infections.
...
PMID:[Clinical evaluation of fleroxacin in gynecological infections]. 190 63
Biliary glycoprotein I (BGP I), a constituent of normal bile and serum, is a glycoprotein (mol. wt. approximately 90,000) containing about 40% carbohydrate. Serum BGP I (S-BGP I) was determined by means of a double-antibody radioimmunoassay in patients with liver and
gastrointestinal disease
and in healthy individuals. The serum levels of five liver enzymes (aspartate aminotransferase,
alanine aminotransferase
, alkaline phosphatase (S-ALP), gamma-glutamyltranspeptidase (S-GT), and lactic dehydrogenase), bilirubin (total and conjugated), and bile acids (cholic and chenodeoxycholic acid) were determined in parallel. Healthy individuals had 0.5 +/- 0.3 mg/l of S-BGP I (mean +/- 2 S.D.; range, 0.2-0.9 mg/l). Most patients with liver disease (chronic hepatitis, alcoholic cirrhosis, primary biliary cirrhosis) had elevated levels, up to 5-10 times the upper reference limit, whereas most patients with
gastrointestinal disease
(ulcerative colitis, Crohn's disease, other GI diseases) had normal values. In patients with liver disease S-BGP I was positively correlated (p less than 0.0005) to S-GT. In primary biliary cirrhosis a positive correlation (p less than 0.005) between S-BGP I and S-ALP was also obtained. All other comparisons between S-BGP I and the other liver function tests showed non-significant correlations. It is concluded that S-BGP I is a determinant of cholestasis of similar use as S-GT.
...
PMID:Serum level of biliary glycoprotein I, a determinant of cholestasis, of similar use as gamma-glutamyltranspeptidase. 611 67
The C57BL/6J mouse strain is widely used as a common genomic background for many gene-modified murine models. However, few data on its clinical biochemistry are available. Therefore, we conducted a study to provide new protocols for serum biochemical screening and developed the reference range for a set of 13 analytes that pertain to lipoprotein metabolism, electrolyte balance, and data reflecting function of the heart, liver, kidneys, and pancreas. Male and female mice were studied, and blood samples were obtained at six and 20 weeks of age. Of 13 parameters studied, 12 were affected by age and sex. Briefly, male mice had higher triglycerides, cholesterol, high-density lipoprotein cholesterol, glucose, and amylase values. With age, mice of both sexes developed higher triglycerides and glucose concentrations, as well as aspartate and
alanine transaminase
activities. A significant difference between mice and humans was noted for amylase activity, which is extremely high in this healthy mouse strain. Therefore, we suggest that caution should be taken when data are interpreted to indicate
gastrointestinal disease
in murine models. The reference values for murine clinical biochemical analytes obtained during the study reported here should be useful for characterizing the biochemical phenotype of experimental mice.
...
PMID:Effect of sex and age on serum biochemical reference ranges in C57BL/6J mice. 1513 63